The FDA granted fast track designation for CTx001, an investigational gene therapy candidate for geographic atrophy secondary ...

Complement Therapeutics GmbH (CTx), a clinical-stage biotechnology company developing next-generation therapeutics for complement-mediated diseases, today announced that the U.S. Food and Drug ...

US FDA grants fast track designation to Complement Therapeutics’ gene therapy candidate CTx001 to treat geographic atrophy: Munich Saturday, January 10, 2026, 17:00 Hrs [IST] Co ...

A replay of the webcast will be archived on the Annexon website for 30 days following the presentation. Annexon Biosciences (Nasdaq: ANNX) is advancing the next generation platform of targeted ...

Potential to Be the First Targeted Fast-Acting Therapy for GBS, Setting a New Standard of Care BLA Submission with U.S./European Data from ...

One of only two Chihuly exhibitions in the world in 2026, CHIHULY at Meijer Gardens Presented by Macatawa Bank is a major exhibition of international significance. The experience spans both the ...

Electricity has always been central to how life works, from the firing of neurons to the beating of the heart, but new ...

Nearby, the Tropical Garden creates a lush oasis that feels like a Caribbean getaway, complete with bananas, bird of paradise, and other exotic plants that somehow survive Virginia winters thanks to ...

Norfolk Botanical Garden is the botanical equivalent of finding out your quiet neighbor is secretly a world-class opera singer—it’s that unexpected and that magnificent. The moment you arrive, you’re ...

Pegcetacoplan significantly reduces proteinuria in patients with recurrent C3 glomerulopathy, or primary immune-complex ...

From football fields to military training grounds, head injuries are leaving lasting marks on the brain in ways we're only ...

A component of the complement system promotes tumor growth by activating myeloid-derived suppressor cells. Figure 1: Multiple pro-inflammatory mediators in the tumor microenvironment increase the ...